Udenafil

GENITO URINARY SYSTEM AND SEX HORMONES

Key facts

Udenafil is a drug catalogued in DrugCentral. It was first approved by the Korean Food and Drug Administration (KFDA) in 2005. DrugCentral lists 2 molecular targets, including PDE5A and ABCB1. Recorded indications include Impotence.

• Molecular targets: PDE5A and ABCB1 (2 listed in DrugCentral).
• Indications: Impotence.
• ATC code: G04BE11 (Drugs used in erectile dysfunction).
• Molecular formula: C25H36N6O4S; molecular weight 516.66 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Impotence

Mechanism & targets

Molecular targets (2)

Target	Gene	Action	Activity
cGMP-specific 3',5'-cyclic phosphodiesterase	PDE5A	inhibitor	IC50 8.08
Multidrug resistance protein 1	ABCB1	unknown	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
2005-12-31	Korean Food and Drug Administration (KFDA)	—	—

ATC classification

ATC code	Therapeutic hierarchy
G04BE11	GENITO URINARY SYSTEM AND SEX HORMONES › UROLOGICALS › UROLOGICALS › Drugs used in erectile dysfunction

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Udenafil is on its molecule page.

• Molecular formula: C₂₅H₃₆N₆O₄S
• Molecular weight: 516.66 g/mol
• CAS number: 268203-93-6
• InChIKey: IYFNEFQTYQPVOC-UHFFFAOYSA-N
• PubChem CID: 135413547

CCCOC1=CC=C(C=C1C1=NC(=O)C2=C(N1)C(CCC)=NN2C)S(=O)(=O)NCCC1CCCN1C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Udenafil used for?

DrugCentral lists the following indications for Udenafil: Impotence.

How does Udenafil work?

Its molecular targets in DrugCentral include PDE5A (inhibitor) and ABCB1.

When was Udenafil first approved?

Udenafil was first approved by the Korean Food and Drug Administration (KFDA) in 2005.

What is the chemical formula of Udenafil?

Udenafil has the molecular formula C25H36N6O4S and a molecular weight of 516.66 g/mol.

Sources

• DrugCentral drug card 4141 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2103849 — compound record and bioactivity
• PubChem CID 135413547 — chemical identifiers
• DrugBank DB06267 — drug record
• FDA UNII L5IB4XLY36 — substance identity
• UniProt O76074 (PDE5A) — target protein
• UniProt P08183 (ABCB1) — target protein

How this page is built: methodology · editorial policy & corrections.